An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia

Lund-Katz, 2010, High density lipoprotein structure-function and role in reverse cholesterol transport, Subcell. Biochem., 51, 183, 10.1007/978-90-481-8622-8_7

Brooks-Wilson, 1999, Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nat. Genet., 22, 336, 10.1038/11905

Rust, 1999, Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1, Nat. Genet., 22, 352, 10.1038/11921

Bodzioch, 1999, The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease, Nat. Genet., 22, 347, 10.1038/11914

Hirsch-Reinshagen, 2004, Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain, J. Biol. Chem., 279, 41197, 10.1074/jbc.M407962200

Wahrle, 2004, ABCA1 is required for normal CNS apoE levels and for lipidation of astrocyte-secreted apoE, J. Biol. Chem., 279, 40987, 10.1074/jbc.M407963200

Fredrickson, 1961, Tangier disease: combined clinical staff conference at the National Institutes of Health, Ann. Intern. Med., 55, 1016, 10.7326/0003-4819-55-6-1016

Dietschy, 2001, Cholesterol metabolism in the brain, Curr. Opin. Lipidol., 12, 105, 10.1097/00041433-200104000-00003

Fan, 2009, Greasing the wheels of Aβ clearance in Alzheimer's disease: the role of lipids and apolipoprotein E, Biofactors., 35, 239, 10.1002/biof.37

Chattopadhyay, 2007, Lipid-protein interaction, regulation and dysfuntion of brain cholesterol, Biochem. Biophys. Res. Commun., 354, 627, 10.1016/j.bbrc.2007.01.032

Vanier, 2010, Neimann-Pick disease type C, Orphanet J. Rare Dis., 5, 16, 10.1186/1750-1172-5-16

Ladu, 2000, Lipoproteins in the central nervous system, Ann. N. Y. Acad. Sci., 903, 167, 10.1111/j.1749-6632.2000.tb06365.x

Pitas, 1987, Lipoproteins and their receptors in the central nervous system, J. Biol. Chem., 262, 14352, 10.1016/S0021-9258(18)47945-8

Saito, 1997, Marked increases in concentrations of apolipoproteins in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury, Biochem. J., 321, 145, 10.1042/bj3210145

Song, 1997, Cerebrospinal fluid apoE and apoA-I concentrations in early- and late-onset Alzheimer's disease, Neurosci. Lett., 231, 175, 10.1016/S0304-3940(97)00558-2

Demeester, 2000, Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin:cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease, J. Lipid Res., 41, 963, 10.1016/S0022-2275(20)32039-3

Koch, 2001, Characterization of four lipoprotein classes in human cerebrospinal fluid, J. Lipid Res., 42, 1143, 10.1016/S0022-2275(20)31605-9

Linton, 1991, Phenotypes of apoliprotein B and apolipoprotein E after liver transplantation, J. Clin. Invest., 88, 270, 10.1172/JCI115288

Ladu, 1998, Nascent astrocyte particles differ from lipoproteins in CSF, J. Neurochem., 70, 2070, 10.1046/j.1471-4159.1998.70052070.x

Lee, 2010, The role of microglia in amyloid clearance from the AD brain, J. Neural Transm., 117, 949, 10.1007/s00702-010-0433-4

Mahley, 2000, Apolipoprotein E: far more than a lipid transport protein, Annu. Rev. Genomics Hum. Genet., 1, 507, 10.1146/annurev.genom.1.1.507

Bertram, 2010, The genetics of Alzheimer disease: back to the future, Neuron., 68, 270, 10.1016/j.neuron.2010.10.013

Corder, 1993, Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families, Science., 261, 921, 10.1126/science.8346443

Corder, 1994, Protective effect of apolipoprotein E type 2 for late onset Alzheimer disease, Nat. Genet., 7, 180, 10.1038/ng0694-180

Hirsch-Reinshagen, 2005, The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's disease, J. Biol. Chem., 280, 43243, 10.1074/jbc.M508781200

Wahrle, 2005, Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease, J. Biol. Chem., 280, 43236, 10.1074/jbc.M508780200

Koldamova, 2005, The liver X receptor ligand TO901317 decreases amyloid β production in vitro and in a mouse model of Alzheimer's disease, J. Biol. Chem., 280, 4079, 10.1074/jbc.M411420200

Wahrle, 2008, Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease, J. Clin. Invest., 118, 671

Jiang, 2008, ApoE promotes the proteolytic degradation of Abeta, Neuron., 58, 681, 10.1016/j.neuron.2008.04.010

Verghese, 2011, Apolipoprotein E in Alzheimer's disease and other neurological disorders, Lancet Neurol., 10, 241, 10.1016/S1474-4422(10)70325-2

Rothblat, 2010, High-density lipoprotein heterogeneity and function in reverse cholesterol transport, Curr. Opin. Lipidol., 21, 229, 10.1097/MOL.0b013e328338472d

Cavigiolio, 2008, The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses, Biochemistry., 47, 4770, 10.1021/bi7023354

Timmins, 2005, Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteimemia and kidney hypercatabolism of apoA-I, J. Clin. Invest., 115, 1333, 10.1172/JCI200523915

Brunham, 2006, Intestinal ABCA1 directly contributes to HDL biogenesis in vivo, J. Clin. Invest., 116, 1052, 10.1172/JCI27352

Asztalos, 2007, Role of LCAT in HDL remodeling: investigation of LCAT deficiency states, J. Lipid Res., 48, 592, 10.1194/jlr.M600403-JLR200

Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science., 271, 518, 10.1126/science.271.5248.518

Fagan, 1999, Unique lipoproteins secreted by primary astrocytes from wild type, wild type, apoE (-/-), and human apoE transgenic mice, J. Biol. Chem., 274, 30001, 10.1074/jbc.274.42.30001

DeMattos, 2001, Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice, Neurochem. Int., 39, 415, 10.1016/S0197-0186(01)00049-3

Hirsch-Reinshagen, 2007, Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease, Curr. Opin. Lipidol., 18, 325, 10.1097/MOL.0b013e32813aeabf

McNeish, 2000, High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1, Proc. Natl. Acad. Sci. U SA., 97, 4245, 10.1073/pnas.97.8.4245

Ryan, 2003, Optimized bacterial expression of human apolipoprotein A-I, Protein Expr. Purif., 27, 98, 10.1016/S1046-5928(02)00568-5

Rensen, 2000, Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo, J. Biol. Chem., 275, 8564, 10.1074/jbc.275.12.8564

Fazio, 1999, Recycling of apolipoprotein E in mouse liver, J. Biol. Chem., 274, 8247, 10.1074/jbc.274.12.8247

Fazio, 2000, The cell biology and physiologic relevance of ApoE recycling, Trends Cardiovasc. Med., 10, 23, 10.1016/S1050-1738(00)00033-5

Swift, 2001, A recycling pathway for resecretion of internalized apolipoprotien E in liver cells, J. Biol. Chem., 276, 22965, 10.1074/jbc.M100172200

Ladu, 2000, Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures, J. Biol. Chem., 275, 33974, 10.1074/jbc.M000602200

Braun, 2006, Intracellular trafficing of recycling apolipoprotein E in Chinese hamster ovary cells, J. Lipid Res., 47, 1176, 10.1194/jlr.M500503-JLR200

Heeren, 2003, Recycling of apolipoprotein E is associated with cholesterol efflux and high density lipoprotein internalization, J. Biol. Chem., 278, 14370, 10.1074/jbc.M209006200

Heeren, 2006, Apolipoprotein E recycling implications for dyslipidemia and atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 26, 442, 10.1161/01.ATV.0000201282.64751.47

Hasty, 2005, The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I, J. Lipid Res., 46, 1433, 10.1194/jlr.M400418-JLR200

Farkas, 2003, The recycling of apolipoprotein E in primary cultures of mouse hepatocytes, J. Biol. Chem., 278, 9412, 10.1074/jbc.M208026200

Bencharif, 2010, Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes, Lipids Health Dis., 9, 75, 10.1186/1476-511X-9-75

Dory, 1991, Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages, J. Lipid Res., 32, 783, 10.1016/S0022-2275(20)42030-9

Dory, 1989, Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux, J. Lipid Res., 30, 809, 10.1016/S0022-2275(20)38303-6

Rellin, 2008, Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells, Biochim. Biophys. Acta., 1781, 232, 10.1016/j.bbalip.2008.02.001

Kockx, 2004, Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux, J. Biol. Chem., 279, 25966, 10.1074/jbc.M401177200

Catte, 2006, Novel changes in discoidal high density lipoprotein morphology: a molecular dynamics study, Biophys. J., 90, 4345, 10.1529/biophysj.105.071456

Zhang, 2011, Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy, J. Lipid Res., 52, 175, 10.1194/jlr.D010959

Ladu, 2006, Self-assembly of HEK cell-secreted apoE particles resembes apoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein, Biochemistry., 45, 381, 10.1021/bi051765s

Rensen, 1997, Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo, J. Lipid Res., 38, 1070, 10.1016/S0022-2275(20)37190-X

Farkas, 2004, The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways, J. Lipid Res., 45, 1546, 10.1194/jlr.M400104-JLR200

Heeren, 2001, Recycling of apolipoprotein E and lipoprotein lipase through endosomeal compartments in vivo, J. Biol. Chem., 276, 42333, 10.1074/jbc.M107461200

Takahashi, 1999, Cholesterol efflux to apolipoprotein A1 involves endocytosis and resecretion in a calcium-dependent pathway, Proc. Natl. Acad. Sci. U SA., 96, 11358, 10.1073/pnas.96.20.11358

Neufeld, 2004, The ABCA1 transporter modulates late endocytic trafficking, J. Biol. Chem., 279, 15571, 10.1074/jbc.M314160200

Denis, 2008, ATP-binding cassett A1-mediated lipidation of apoA-I occurs at the plasma membrane and not in the endocytic compartment, J. Biol. Chem., 283, 16178, 10.1074/jbc.M709597200

Lefterov, 2010, Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1E9 mice, J. Biol. Chem., 285, 36945, 10.1074/jbc.M110.127738

Lewis, 2010, Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer's disease, J. Biol. Chem., 285, 36958, 10.1074/jbc.M110.127829

Fagan, 2004, ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis, Am. J. Pathol., 165, 1413, 10.1016/S0002-9440(10)63399-8

Heeren, 2004, Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation, J. Biol. Chem., 279, 55483, 10.1074/jbc.M409324200

Zhong, 2009, Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure, J. Biol. Chem., 284, 6027, 10.1074/jbc.R800009200

Zhong, 2009, Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function, J. Biol. Chem., 284, 27273, 10.1074/jbc.M109.014464

Hatters, 2005, Modulation of apolipoprotein E structure by domain interaction, J. Biol. Chem., 280, 34288, 10.1074/jbc.M506044200

Morrow, 2002, Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease, J. Biol. Chem., 277, 50380, 10.1074/jbc.M204898200

Dong, 1994, Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms, J. Biol. Chem., 269, 22358, 10.1016/S0021-9258(17)31797-0

Chen, 2010, ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling, Proc. Natl. Acad. Sci. U SA., 107, 12011, 10.1073/pnas.0914984107

Riddell, 2008, Impact of apolipoprotein E (apoE) polymorphism on brain apoE levels, J. Neurosci., 28, 11445, 10.1523/JNEUROSCI.1972-08.2008

Bertrand, 1995, Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer dsiease, Brain Res. Mol. Brain Res., 33, 174, 10.1016/0169-328X(95)00097-C

Beffert, 1999, Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent, Brain Res., 843, 87, 10.1016/S0006-8993(99)01894-6

Poirier, 2005, Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease, Neurobiol. Aging., 26, 355, 10.1016/j.neurobiolaging.2004.09.003

Glockner, 2002, Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease, Neuroscience., 114, 1103, 10.1016/S0306-4522(02)00178-1

Ramaswamy, 2005, Effect of domain interaction on apolipoprotein E levels in mouse brain, J. Neurosci., 25, 10658, 10.1523/JNEUROSCI.1922-05.2005

Fryer, 2005, Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model, J. Neurosci., 25, 2803, 10.1523/JNEUROSCI.5170-04.2005

Sullivan, 2004, Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice, Neuroscience., 124, 725, 10.1016/j.neuroscience.2003.10.011

Fukumoto, 2003, Age but not diagnosis is the main predictor of plasma amyloid β-protein levels, Arch. Neurol., 60, 958, 10.1001/archneur.60.7.958

Koldamova, 2005, Lack of ABCA1 considerably decreases brain apoE level and increases amyloid deposition in APP23 mice, J. Biol. Chem., 280, 43224, 10.1074/jbc.M504513200